Belumosudil and ruxolitinib combination for treatment of refractory chronic graft-versus-host disease

被引：0
|
作者：
Iskra Pusic
Catherine Lee
Muthu Veeraputhiran
Chelsea Minor
John F. DiPersio
机构：
[1] Washington University School of Medicine,Fred Hutchinson Cancer Center
[2] Division of Oncology,undefined
[3] Clinical Research Division,undefined
[4] University of Arkansas for Medical Sciences,undefined
[5] Department of Hematology and Medical Oncology,undefined
来源：
Bone Marrow Transplantation | 2024年 / 59卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：282 / 284
页数：2
相关论文
共 50 条
  • [1] Belumosudil and ruxolitinib combination for treatment of refractory chronic graft-versus-host disease
    Pusic, Iskra
    Lee, Catherine
    Veeraputhiran, Muthu
    Minor, Chelsea
    Dipersio, John F.
    BONE MARROW TRANSPLANTATION, 2024, 59 (02) : 282 - 284
  • [2] Belumosudil Combination Therapy in Refractory Chronic Graft-Versus-Host Disease
    Chin, Michelle
    Shizuru, Judith A.
    Muffly, Lori
    Shiraz, Parveen
    Johnston, Laura J.
    Lowsky, Robert
    Rezvani, Andrew R.
    Frank, Matthew J.
    Bharadwaj, Sushma
    Weng, Wen-Kai
    Negrin, Robert S.
    Miklos, David B.
    Arai, Sally
    BLOOD, 2022, 140 : 4788 - 4789
  • [3] Ruxolitinib–ECP combination treatment for refractory severe chronic graft-versus-host disease
    Kristina Maas-Bauer
    Chrissoula Kiote-Schmidt
    Hartmut Bertz
    Petya Apostolova
    Ralph Wäsch
    Gabriele Ihorst
    Jürgen Finke
    Robert Zeiser
    Bone Marrow Transplantation, 2021, 56 : 909 - 916
  • [4] Combination treatment of extracorporeal photopheresis and belumosudil for chronic graft-versus-host disease
    Swallow, Madisen A.
    Chang, Jungsoo
    Carlson, Kacie R.
    Odell, Ian
    Girardi, Michael
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)
  • [5] Ruxolitinib-ECP combination treatment for refractory severe chronic graft-versus-host disease
    Maas-Bauer, Kristina
    Kiote-Schmidt, Chrissoula
    Bertz, Hartmut
    Apostolova, Petya
    Waesch, Ralph
    Ihorst, Gabriele
    Finke, Juergen
    Zeiser, Robert
    BONE MARROW TRANSPLANTATION, 2021, 56 (04) : 909 - 916
  • [6] Belumosudil for chronic graft-versus-host disease
    Taylor, Breanna
    Cohen, Jaimie
    Tejeda, Jennifer
    Wang, Trent Peng
    DRUGS OF TODAY, 2022, 58 (05) : 203 - 212
  • [7] Ruxolitinib for the treatment of steroid refractory pediatric chronic graft-versus-host disease
    Belina, Morgan E.
    Driscoll, Timothy A.
    Blanchard, Sarah K.
    Cardones, Adela R.
    PEDIATRIC DERMATOLOGY, 2022, 39 (03) : 432 - 433
  • [8] Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease
    Zeiser, Robert
    Polverelli, Nicola
    Ram, Ron
    Hashmi, Shahrukh K.
    Chakraverty, Ronjon
    Middeke, Jan Moritz
    Musso, Maurizio
    Giebel, Sebastian
    Uzay, Ant
    Langmuir, Peter
    Hollaender, Norbert
    Gowda, Maanasa
    Stefanelli, Tommaso
    Lee, Stephanie J.
    Teshima, Takanori
    Locatelli, Franco
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (03): : 228 - 238
  • [9] Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease
    Kaloyannidis, Panayotis
    Al Shaibani, Eshrak
    Apostolidis, Ioannis
    Kanfar, Solaf
    Al Anezi, Khalid
    Al Hashmi, Hani
    BONE MARROW TRANSPLANTATION, 2019, 54 (05) : 746 - 748
  • [10] Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease
    Panayotis Kaloyannidis
    Eshrak Al Shaibani
    Ioannis Apostolidis
    Solaf Kanfar
    Khalid Al Anezi
    Hani Al Hashmi
    Bone Marrow Transplantation, 2019, 54 : 746 - 748
12345